Your browser doesn't support javascript.
loading
Adverse events and efficacy of second-round CAR-T cell therapy in relapsed pediatric B-ALL.
Ji, Qi; Wu, Xiaochen; Zhang, Yongping; Zeng, Liang; Dong, Yi; Liu, Ruiqing; Li, Bohan; Bai, Zhenjiang; Hu, Shaoyan; Lu, Jun; Wu, Shuiyan.
Afiliación
  • Ji Q; Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Wu X; Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Zhang Y; Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Zeng L; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Dong Y; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Liu R; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Li B; Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Bai Z; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Hu S; Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Lu J; Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Wu S; Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Eur J Haematol ; 112(1): 75-82, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37649264

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Límite: Child / Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Límite: Child / Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China